EMERYVILLE, Calif.,
March 16, 2021 /PRNewswire/
-- Amyris, Inc. (Nasdaq: AMRS), a leading synthetic
biotechnology company active in the Clean Health and Beauty markets
through its consumer brands and a top supplier of sustainable and
natural ingredients, announced today that it has signed a
memorandum of understanding for a partnership with Minerva Foods of
Brazil to develop molecules for
the sustainable production and distribution of animal protein.
Minerva will fund Amyris's development, scaling and production
of new target molecules (with additional molecules to be identified
over time), which Minerva will then be responsible for
commercializing. The parties expect to begin commercialization of
the first product within 18 months. The new molecules will include
natural preservatives from fermentation that will enable meat to be
transported and sold with a longer shelf-life at reduced
CO2 emission levels. The parties may also work on the
development and production of a fermentation-based alternative to
animal-based protein.
Minerva Foods is a global leader in the production and sale of
fresh beef and beef by-products, live cattle exports, and processed
meat. It also operates in protein trading in export markets and
resale of third-party products.
"We are very pleased to partner with Amyris, the leader in
synthetic biotechnology and the world's leading fermentation
technology company," said Fernando Galletti
De Queiroz, Chief Executive Officer of Minerva. "We envision
a world where consumption of animal protein will continue and the
demand for alternatives will grow. With Amyris's clean fermentation
technology, we expect to lead the disruption of the animal protein
industry and reduce our industry's carbon footprint."
"With our partnership with Minerva, we continue our growth
through a tradition of collaborating with market leaders who have a
deep understanding of their end-markets," commented John Melo, President and Chief Executive Officer
of Amyris. "Minerva is a leader in animal protein production that
is committed to reducing carbon emissions in the entire animal
protein production value chain through innovation of its industry.
This partnership is expected to deliver several million dollars in
collaboration revenue this year as well as contribute to our
long-term product revenue growth. We are excited to expand our
platform into the fermentation-based protein market with one of the
world's leading producers of meat."
The parties expect to sign definitive agreements in the next
several weeks, followed by closing in Q2 2021, subject to customary
closing conditions.
About Minerva Foods
Minerva S.A. or Minerva Foods
(BVMF: BEEF3) is the largest exporter of beef in South America and one of the leading companies
in Brazil for the production and
sale of both in natura (chilled) and frozen beef, processed protein
products, live cattle, and sub-products. Minerva Foods was founded
in 1992 in the city of Barretos, in the countryside of the State of
São Paulo, where it is headquartered. From the beginning, Minerva
Foods has had a clear goal of expanding globally and diversifying
its operations geographically. In 2017, the company acquired
nine beef abattoirs in South
America, establishing itself as the most diversified beef
producer in terms of location, products offered, and presence in
the external markets. Minerva Foods now operates plants in
Brazil, Argentina, Colombia, Paraguay, and Uruguay.
About Amyris
Amyris (Nasdaq: AMRS) is a science and
technology leader in the research, development and production of
sustainable ingredients for the Clean Health & Beauty and
Flavors & Fragrances markets. Amyris uses an impressive array
of exclusive technologies, including state-of-the-art machine
learning, robotics and artificial intelligence. Our ingredients are
included in over 3,000 products from the world's top brands,
reaching more than 200 million consumers. Amyris is proud to own
three consumer brands - all built around its No Compromise® promise
of clean ingredients: Biossance® clean beauty
skincare, Pipette® clean baby skincare and
Purecane™, a zero-calorie sweetener naturally derived from
sugarcane. For more information, please visit www.amyris.com.
Forward-Looking Statements
This release contains
forward-looking statements, and any statements other than
statements of historical fact could be deemed to be forward-looking
statements. These forward-looking statements include, among other
things, statements regarding Amyris's plans to develop, scale and
produce new target molecules through funding provided by Minerva,
and the timing thereof; expectations of commencing
commercialization within 18 months; expectations that the molecules
will enable meat to be transported and sold with a longer
shelf-life at reduced CO2 emission levels; the potential
that the parties may develop and produce a fermentation-based
alternative to animal-based protein; Amyris's expectations
regarding short- and long-term revenue and growth potential derived
from its collaboration with Minerva; and timing expectations
regarding signing of definitive agreements by Q2 2021. These
statements are based on management's current expectations and
actual results and future events may differ materially due to risks
and uncertainties, potential delay and failure to sign and close
the agreements between Amyris and Minerva; potential delays or
failures in development, production, regulatory approval and
commercialization of new molecules and products; failure to realize
the expected benefits of the partnership with Minerva; risks
related to Amyris's reliance on third parties (including in the
supply chain); risks related to Amyris's liquidity and ability to
fund operating and capital expenses; and other risks detailed from
time to time in filings Amyris makes with the Securities and
Exchange Commission, including Annual Reports on Form 10-K,
Quarterly Reports on Form 10-Q and Current Reports on Form 8-K.
Amyris disclaims any obligation to update information contained in
these forward-looking statements, whether as a result of new
information, future events, or otherwise.
Amyris, the Amyris logo, No Compromise, Biossance, Pipette, and
Purecane are trademarks or registered trademarks of Amyris, Inc. in
the U.S. and/or other countries.
View original content to download
multimedia:http://www.prnewswire.com/news-releases/amyris-enters-partnership-with-minerva-foods-for-zero-carbon-protein-production-301248049.html
SOURCE Amyris, Inc.